Company Description
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide.
The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices.
It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.
The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles.
In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body.
Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos.
It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings.
Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
| Country | United States |
| Founded | 2010 |
| IPO Date | Jun 3, 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 35 |
| CEO | Joseph C. Sardano |
Contact Details
Address: 851 Broken Sound Parkway Nw, Suite 215 Boca Raton, Florida 33487 United States | |
| Phone | 561-922-5808 |
| Website | sensushealthcare.com |
Stock Details
| Ticker Symbol | SRTS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001494891 |
| CUSIP Number | 81728J109 |
| ISIN Number | US81728J1097 |
| Employer ID | 27-1647271 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Joseph C. Sardano | Co-Founder, Chairman and Chief Executive Officer |
| Michael J. Sardano | President, General Counsel, Corporate Secretary and Director |
| Javier Rampolla | Chief Financial Officer |
| Magdalena Martinez | Chief Operating Officer |
| Emiliano Sosa | Chief Technology Officer |
| Stephanie Tipton | Vice President of Marketing |
| Dr. Mark S. Nestor | Medical Director and Member of Medical Advisory Board |
| Dr. Clay Jefferies Cockerell | Clinical Director and Member of Medical Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 18, 2024 | PRE 14A | Other preliminary proxy statements |
| Mar 15, 2024 | 10-K | Annual Report |
| Feb 8, 2024 | 8-K | Current Report |
| Feb 6, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 2, 2024 | 8-K | Current Report |
| Jan 18, 2024 | 8-K | Current Report |
| Nov 13, 2023 | 10-Q | Quarterly Report |
| Nov 9, 2023 | 8-K | Current Report |
| Sep 14, 2023 | 8-K | Current Report |
| Aug 11, 2023 | S-8 | Securities to be offered to employees in employee benefit plans |